Tag: locoregionalRecurrence

Articles

• Latest research concerning HER2 positive breast cancer prognosis
• Latest research concerning hormone receptor positive (ER+/PR+) breast cancer prognosis
• Latest research on breast cancer in very young women
• Latest research on radiation treatment for breast cancer
• Prognosis of triple negative breast cancer compared to other breast cancer subtypes
• When should mastectomy be followed by radiation treatment?

News

• Axillary dissection may not be necessary in some women with positive lymph nodes
• Breast cancer prognosis - risk of locoregional recurrence by breast cancer subtype
• Breast cancer subtype influences prognosis after neoadjuvant chemotherapy
• Breast cancer survivors at higher risk of new breast tumors and endometrial cancer
• Breast reduction surgery may be combined with lumpectomy for DCIS
• Change in HER2 status between primary and recurrence indicates poor prognosis
• Comparable survival between sentinel node biopsy and axillary lymph node dissection
• Dense breasts more likely with a family history of breast cancer - what to do
• ER negative, PR negative, and triple negative tumors have increased risk of locoregional recurrence
• ER+/PR- or ER-/PR+ tumors more likely to recur locally than ER+/PR+ breast cancer
• Herceptin has reduced locoregional recurrence for HER2+ compared to triple negative breast cancer
• Locoregional recurrence indicates poor prognosis 10 or more years after lumpectomy
• Lumpectomy has worse prognosis than mastectomy for young women
• Lumpectomy is not inferior to mastectomy for appropriately selected triple negative patients
• Lumpectomy may be less effective in young breast cancer patients
• Mexican breast cancer patients are younger and more likely to have triple negative breast cancer
• Multivitamins with minerals associated with reduced risk of breast cancer recurrence
• New method predicts progression of DCIS to invasive breast cancer
• No need for axillary lymph node dissection when sentinel lymph node biopsy is negative
• Number of tumors should be considered in staging multicentric/multifocal breast cancer
• Obesity reduces survival after early-stage breast cancer
• Omitting axillary dissection for sentinel node micrometastases means higher risk of recurrence
• Outcomes of breast cancer under age 35 influenced by number of positive lymph nodes
• Radiation after lumpectomy reduces recurrence for DCIS survivors
• Radiation after surgery for DCIS reduces risk of local recurrence
• Radiation treatment may improve prognosis of early stage triple negative breast cancer
• Residual disease can be prevented for many breast cancer patients with 2 mm clean margins
• Risk of DCIS relapse or progression to invasive cancer continues at least 20 years
• Risk of second primary breast cancer highest in hormone receptor negative survivors
• Skin-sparing mastectomy not linked to increased breast cancer recurrence
• Small lymph node negative triple negative tumors can have good prognosis
• Survival after local recurrence is higher in women originally diagnosed under 50 years of age
• Triple negative breast cancer involves increased risk of distant relapse within shorter time
• Young breast cancer patients require aggressive treatment

Studies

• Age <40 Years is an Independent Prognostic Factor Predicting Inferior Overall Survival in Patients Treated with Breast Conservative Therapy
• Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged under 40 years
• Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?
• Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence
• Axillary lymph node failure in patients treated with accelerated partial breast irradiation
• Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up
• Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
• Breast cancer in very young women
• Characteristics and Outcomes of Sentinel Node-Positive Breast Cancer Patients after Total Mastectomy without Axillary-Specific Treatment
• Clinical Outcomes Using Accelerated Partial Breast Irradiation in Patients with Invasive Lobular Carcinoma
• Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society
• Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy
• Conservative surgery in patients with multifocal/multicentric breast cancer
• Factors predicting in-breast tumor recurrence after breast-conserving surgery
• HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
• How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery
• Impact of aggregate of risk factors for isolated locoregional failure in breast cancer patients treated with mastectomy without radiotherapy
• Influence of Lymphatic Invasion on Locoregional Recurrence Following Mastectomy: Indication for Postmastectomy Radiotherapy for Breast Cancer Patients with One to Three Positive Nodes
• Local Recurrence after Breast Cancer Affects Specific Survival Differently according to Patient Age
• Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy
• Locoregional Failure in Early-Stage Breast Cancer Patients Treated with Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit from Postmastectomy Irradiation?
• Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
• Locoregional recurrence after breast conserving therapy remains an independent prognostic factor even after an event free interval of ten years in early stage breast cancer
• Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer
• Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial
• Locoregional Recurrence in Patients With Triple-Negative Breast Cancer: Preliminary Results of a Single Institution Study
• Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy
• Long-Term Outcome in Patients with Ductal Carcinoma in situ Treated with Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies
• Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
• Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution
• Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer
• Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
• Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001
• Multivitamin Use and Breast Cancer Prognosis and Survival in a Prospective Cohort Study: The Life After Cancer Epidemiology (LACE) Study
• Partial Breast Brachytherapy Is Associated with Inferior Effectiveness and Increased Toxicity Compared with Whole Breast Irradiation in Older Patients
• Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer
• Patterns of distant and local relapses in breast cancer patients and triple negative subgroup
• Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
• Prognostic Value of Molecular Subtypes, Ki67 Expression and Impact of Postmastectomy Radiation Therapy in Breast Cancer Patients With Negative Lymph Nodes After Mastectomy
• Radiotherapy Can Decrease Locoregional Recurrence and Increase Survival in Mastectomy Patients With T1 to T2 Breast Cancer and One to Three Positive Nodes With Negative Estrogen Receptor and Positive Lymphovascular Invasion Status
• Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger
• Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells
• Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer
• Risk of Recurrence of Non-Metastatic Breast Cancer in Women Under 40 Years: A Population-Registry Cancer Study in a European Country
• Role of Postmastectomy Radiation After Neoadjuvant Chemotherapy in Stage II-III Breast Cancer
• Surgical Margins and the Risk of Local-Regional Recurrence After Mastectomy Without Radiation Therapy
• Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence
• The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer
• The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials
• The impact of young age on breast cancer outcome
• The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
• Triple-negative breast cancer in Hispanic patients
• Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation
• Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer
• Twenty-five year results of the national cancer institute randomized breast conservation trial